Walleye Capital
BLACU

Walleye Capital’s Bellevue Life Sciences Acquisition Corp. Unit BLACU Stock Holding History

Walleye Capital’s Portfolio BLACU Stock Details BLACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-168,128
Closed -$1.8M – 5640
2023
Q3 		$1.8M Hold
168,128
– – ﹤0.01% 1821
2023
Q2 		$1.78M Hold
168,128
– – 0.01% 1415
2023
Q1 		$1.73M Buy
+168,128
New +$1.72M 0.03% 811

Other funds holding BLACU

CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Walleye Capital's BLACU Position: Q4 2023 in Review

Walleye Capital sold out of Bellevue Life Sciences Acquisition Corp. Unit (BLACU) in Q4 2023, closing a stake of 168,128 shares — an estimated $1.8M sold.

Walleye Capital first reported a position in BLACU in Q1 2023 and held it in 3 quarters. The position peaked at $1.8M in Q3 2023. 2 funds tracked by Wall St. Rank hold BLACU as of Q4 2023.

  • Walleye Capital reported no remaining Bellevue Life Sciences Acquisition Corp. Unit position as of Q4 2023 after selling out during the quarter.
  • Walleye Capital sold 168,128 Bellevue Life Sciences Acquisition Corp. Unit shares in Q4 2023, an estimated $1.8M.
  • Walleye Capital first reported a position in Bellevue Life Sciences Acquisition Corp. Unit in Q1 2023 and held it in 3 quarters.
  • Walleye Capital's Bellevue Life Sciences Acquisition Corp. Unit position peaked at $1.8M in Q3 2023.
  • 2 funds tracked by Wall St. Rank held Bellevue Life Sciences Acquisition Corp. Unit as of Q4 2023.

Based on Walleye Capital's 13F filing for Q4 2023, filed 14 Feb 2024.